A detailed history of Live Oak Investment Partners transactions in Embecta Corp. stock. As of the latest transaction made, Live Oak Investment Partners holds 7 shares of EMBC stock, worth $98. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$98
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$10.13 - $14.6 $50 - $73
-5 Reduced 41.67%
7 $0
Q4 2022

Feb 15, 2023

BUY
$25.29 - $35.48 $303 - $425
12 New
12 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $817M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Live Oak Investment Partners Portfolio

Follow Live Oak Investment Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Live Oak Investment Partners, based on Form 13F filings with the SEC.

News

Stay updated on Live Oak Investment Partners with notifications on news.